CMCSA enters the week before its October 22 earnings with a bruising 7.3% weekly decline to $24.42, fresh analyst target cuts from BofA and UBS, and a stock that now trades well below every major price target on the Street.
The analyst picture has turned demonstrably more cautious. BofA's Jessica Reif Cohen lowered her target this week from $37 to $35, holding a Buy — a vote of confidence undermined somewhat by the sheer size of the cut. UBS trimmed from $32 to $27 on a Neutral rating, the same day. Both moves were filed within the past 48 hours, making them the freshest read on institutional thinking. Pulling back further, the July 24 earnings reaction prompted a wave of cuts — Wells Fargo (Underweight, $23), Barclays (Equal-Weight, $26), and RBC (Sector Perform, $26) all dropped targets after that print. The mean price target now sits at $29.76, implying roughly 22% upside from current levels, but the direction of travel on targets is uniformly downward. Bulls point to the planned NBCU/Sky separation as a potential re-rating catalyst and lean on a deeply discounted valuation; bears flag intensifying fiber competition, broadband pricing pressure, and a balance sheet stretched by prior acquisitions.
Valuation has compressed to levels that look genuinely cheap on paper. The stock trades at a PE of 6.96, down roughly 0.38 turns this week alone. The EV/EBITDA sits at 5.52, also grinding lower. The price-to-book has fallen below 1.0 at 0.87 — a level that normally signals either distress or deep value, depending on which side of the debate you sit. The EV/EBIT factor scores in the 76th percentile, confirming that relative to the broader universe, the stock is priced cheaply. The ORTEX short score of 32.5 is unremarkable, sitting in the 60th percentile of the utilization rank, and has barely moved this week — shorts are not driving the price action.
The lending market confirms that short sellers are not pressing hard here. Availability is exceptionally loose at 5,236% — roughly 52 shares available for every one currently borrowed — which means there is effectively unlimited supply for anyone wanting to establish a new short position. Borrowing costs have eased 14% this week to just 0.40% annualised, close to free. Short interest at 2.2% of the free float is low by any measure, and while it has risen roughly 10% over the past week in share terms, the absolute level remains modest at around 81 million shares. Options positioning is equally uneventful: the put/call ratio of 0.36 is barely above its 20-day average of 0.35, and the z-score of 0.16 signals no unusual hedging demand. The market is not set up for a squeeze, and options traders are not paying for downside protection beyond the norm.
The earnings history deserves attention ahead of October 22. The last two prints produced negative day-one reactions — the July 23 Q2 result knocked the stock down 5.2% on the session, and the July 30 event produced a further 2.6% decline the following day. Five-day recoveries were modest in both cases. That pattern of selling on results then stabilising is worth keeping in mind as the next reporting date approaches. Among peers, the divergence this week is notable: VZ added 2.1% while LILA gained 2.2%, both moving in the opposite direction from Comcast's 7.3% slide. The company-specific nature of the weakness — structural cable concerns rather than sector-wide pressure — is reinforced by that split.
What to watch into October 22 is whether the Street's target cuts stabilise around the current cluster of $26–$35, or whether the next wave of analyst revisions breaks the lower bound — with Wells Fargo already at $23 and BNP Paribas at $22, the downside scenario on targets is not far from where the stock is trading now.
See the live data behind this article on ORTEX.
Open CMCSA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.